• Globe Newswire

Safety Shot Expects Approximately 50% Revenue Growth in Q4

Globenewswire -

• Globe Newswire

Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist compound IRX5010 in treatment of a mouse model of triple negative breast cancer, demonstrating combination treatment effects with an anti-PDL-1 monoclonal antibody

Globenewswire -

• Globe Newswire

Repeat: Thunder Bridge Capital Partners IV, Inc. Announces Effectiveness of Registration Statement and Special Meeting Date for Proposed Business Combination with Coincheck, Inc.

• Globe Newswire

The Sanborn Map Company, Inc. Receives Certification to ISO 9001:2015 Standard

• Globe Newswire

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

• Globe Newswire

Berman Tabacco Announces Investigation of Evolv Technologies Holdings, Inc. (EVLV, EVLVW) Concerning Accounting Practices

• Globe Newswire

Dark Horse Consulting Group Acquires BioTechLogic, Inc.